期刊文献+

慢性阻塞性肺疾病患者SGRQ与BODE指数及其相关性的应用研究进展 被引量:2

原文传递
导出
摘要 慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)在全世界范围内是一种发病率和死亡率较高的重要疾病,造成严重的经济和社会负担,而且这种负担在不断增加,预计到2020年,在全球疾病经济负担的排名之中,COPD将跃居至第五位,而死亡率可能上升至第三位。吸烟和其他有害颗粒的吸入,例如生物燃料等所导致的肺部终末细支气管慢性炎症,是发生COPD的重要原因。这一慢性炎症反应导致肺部正常的防御与修复功能受到破坏,进而诱发肺实质的破坏,造成小气道的纤维化。
出处 《中华临床医师杂志(电子版)》 CAS 2013年第14期190-191,共2页 Chinese Journal of Clinicians(Electronic Edition)
基金 哈尔滨市科技攻关项目(2008AA3BS098)
  • 相关文献

参考文献18

  • 1GOLD Executive Commit ee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease(Updated 2007)[OL].http://www.goldcopd.com,.
  • 2Rhazi K,Nejjari C,Benjelloun MC. Validation of the St.George's respiratory questionnaire in patients with COPD or asthma in morocco[J].International Journal of Tuberculosis and Lung Disease,2006.1273-1278.
  • 3蔡柏蔷.慢性阻塞性肺疾病患者的生活质量评估[J].中国康复理论与实践,2009,15(5):405-407. 被引量:41
  • 4蔡柏蔷;李龙芸.慢性阻塞性肺疾病.协和呼吸病学.2 版协和呼吸病学.2 版[M].北京:中国协和医科大学出版社,20111076-1113.
  • 5celli BR,Cote CG,Marin JM. The body-mass index,airflow obstruction,dyspnea,and exercise capacity index in chronic obstructive pulmonary disease[J].New England Journal of Medicine,2004.1005-1012.
  • 6Gudmundsson G,Gislason T,Lindberg E. Mortality in COPD patients discharged from hospital:the role of treatment and co-morbidity[J].Respiratory Research,2006.109.
  • 7Galbraith JK. The Affluent Society. 40 ed[M].Mariner Books,1998.288.
  • 8Benninger MS,Ferguson BJ,Hadley JA. Adult chronic rhinosinusitis:definitions, diagnosis, epidemiology, and pathophysiology[J].Otolaryngology-Head & Neck Surgery,2003.S1-S32.
  • 9GOLD Executive Commit ee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease(Updated 2013)[OL].http://www.goldcopd.com,.
  • 10Murray CJL,Lopez AD. Mortality by cause for eight regions of the world:Global Burden of Disease Study[J].Lancet,1997.1269-1276.

二级参考文献31

  • 1杨铮,刘晓鹏,万崇华,李晓梅,杨玉萍.慢性呼吸系统疾病生命质量测定量表研究概况[J].中华结核和呼吸杂志,2005,28(11):791-793. 被引量:13
  • 2Nicolas J. Gross, Outcome Measures for COPD Treatments: A critical evaluation[J]. Clin Rev, 2004, 1(1):41-57.
  • 3Curtis JR, Patrick DL. The assessment of health status among patients with COPD[J]. Eur Respir J, 2003, 21(Suppl 41): 36s-45s.
  • 4Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation. The St. George's respiratory qustionare[J]. Am Rev Respir Dis, 1992, 145: 1321-1327.
  • 5Jones PW, Quirk FH, Baveystock CM. The St. George's respirato ry qustionare[J]. Respir Med, 1991,85(Suppl B):25-31.
  • 6Engstrom CP, Persson LO, Larsson S, et al. Health-related quality of life in COPD: why both disease-specific and generic measures should be used[J]. Eur Respir J, 2001, 18:69-76.
  • 7Molken MR, Roos B, Van Noord JA. An empirical comparison of the St. George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in the clinical trial setting [J]. Thorax, 1999,54:995-1003.
  • 8Curtis JR, Deyo RA, Hudson LD. Health related quality of life among patients with chronic obstructive pulmonary disease[J]. Tho rax, 1994,49: 162-170.
  • 9GOLD Executive Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (Updated 2007)[OL]. www. goldcopd. com.
  • 10GOLD Executive Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease ( Revised 2011 ). www. goldeopd, com.

共引文献976

同被引文献13

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部